Colorectal cancer (CRC) is the second most common cancer in China, the morbidity and
mortality rates of which are rapidly increasing 1, 2. Among newly-diagnosed CRC patients …

Colorectal cancer (CRC) represents approximately 10% of all cancers and is the second
most common cause of cancer deaths. Initial clinical presentation as metastatic CRC …

Colorectal cancer (CRC) is the second leading cause of cancer dead in Spain. About half
the patients will eventually develop distant metastases. However, as treatment options are …

Introduction: Metastatic colorectal cancer (CRC) remains a dilemma for cancer researchers
with an increasing incidence in the younger patient population. Until the last decade, limited …

In the last year, several impactful updates have been added to the NCCN Guidelines for
Colorectal Cancer (CRC) for the management of metastatic disease, including additional …

Introduction: Since late 1990's therapy of metastatic colorectal cancer (mCRC) patients has
changed considerable, and the combination of doublet or triplet chemotherapy and a …

Colorectal cancer remains one of the most common cancers worldwide and is almost
uniformly fatal for those with metastatic disease. Despite this, there is an increasing number …

Significant progress has been achieved in the treatment of metastatic colorectal cancer
(mCRC) patients during the last 20 years. There are currently numerous treatments …

Colorectal cancer (CRC) is the third most common cancer worldwide, with 1.1 million new
cases per year, and is the second leading cause of cancer death. 1 CRC occurs more …

Simple Summary Metastatic colorectal cancer (mCRC) represents a significant burden in
cancer-related morbidity and mortality. The study of mCRC-related genetic alterations and …